Comparing the effects of different types of cardiac rehabilitation programs on modifiable risk factors of cardiovascular disease and cardiac function in patients who underwent angioplasty

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20240123060775N1

Enrollment

Registered

2024-01-28

Start date

2024-01-27

Completion date

Unknown

Last updated

2024-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with acute coronary syndrome who underwent coronary angioplasty. ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction

Interventions

Intervention 1: Intervention group: The first intervention group are patients who, after passing a training session to learn sports movements, how to control vital signs and recognize danger signs, re

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with an acute coronary syndrome treated with primary or elective Percutaneous Coronary Intervention Men and women who signed informed consent Patients are able to regularly attend a supervised exercise program and able to complete Persian language questionnaires

Exclusion criteria

Exclusion criteria: Severe arrhythmias Heart valve disease Severe comorbidities which limit the Cardiac Rehabilitation (i.n. severe COPD, severe diabetes or locomotive disorder) patients with an implantable cardioverter-defibrillator uncontrolled hypertension

Design outcomes

Primary

Measure	Time frame
Mental health status score in MacNew questionnaire. Timepoint: The beginning of the intervention and 4 months after the start. Method of measurement: MacNew questionnaire.;The percentage of people with blood pressure above 120/80 mm Hg. Timepoint: The beginning of the intervention, 2 and 4 months after the start. Method of measurement: Mercury sphygmomanometer.;Percentage of people with a BMI above 25 kg/m². Timepoint: The beginning of the intervention, 2 and 4 months after the start. Method of measurement: Scales and measuring meter.;The percentage of people who have blood sugar more than 100 mg/dL. Timepoint: The beginning of the intervention, 2 and 4 months after the start. Method of measurement: Blood sugar test.;The percentage of people who have total cholesterol more than 200 mg/dL. Timepoint: The beginning of the intervention, 2 and 4 months after the start. Method of measurement: Blood cholesterol test.;The percentage of people who have HDL less than 50 mg/dL. Timepoint: The beginning of the intervention, 2 and 4 months after the start. Method of measurement: Blood HDL test.;The percentage of people with LDL more than 100 mg/dL. Timepoint: The beginning of the intervention, 2 and 4 months after the start. Method of measurement: Blood LDL test.;The percentage of people who have triglycerides more than 150 mg/dL. Timepoint: The beginning of the intervention, 2 and 4 months after the start. Method of measurement: Blood triglyceride test.;The percentage of people who have a ratio of neutrophils to lymphocytes greater than 3. Timepoint: The beginning of the intervention, 2 and 4 months after the start. Method of measurement: Complete blood count test.;The percentage of people who have a platelet to lymphocyte ratio greater than 150. Timepoint: The beginning of the intervention, 2 and 4 months after the start. Method of measurement: Complete blood count test.;The percentage of people who have cardiac ejection fraction less than 50%. Timepoint: The beginning of the	—

Measure

Time frame

Mental health status score in MacNew questionnaire. Timepoint: The beginning of the intervention and 4 months after the start. Method of measurement: MacNew questionnaire.;The percentage of people with blood pressure above 120/80 mm Hg. Timepoint: The beginning of the intervention, 2 and 4 months after the start. Method of measurement: Mercury sphygmomanometer.;Percentage of people with a BMI above 25 kg/m². Timepoint: The beginning of the intervention, 2 and 4 months after the start. Method of measurement: Scales and measuring meter.;The percentage of people who have blood sugar more than 100 mg/dL. Timepoint: The beginning of the intervention, 2 and 4 months after the start. Method of measurement: Blood sugar test.;The percentage of people who have total cholesterol more than 200 mg/dL. Timepoint: The beginning of the intervention, 2 and 4 months after the start. Method of measurement: Blood cholesterol test.;The percentage of people who have HDL less than 50 mg/dL. Timepoint: The beginning of the intervention, 2 and 4 months after the start. Method of measurement: Blood HDL test.;The percentage of people with LDL more than 100 mg/dL. Timepoint: The beginning of the intervention, 2 and 4 months after the start. Method of measurement: Blood LDL test.;The percentage of people who have triglycerides more than 150 mg/dL. Timepoint: The beginning of the intervention, 2 and 4 months after the start. Method of measurement: Blood triglyceride test.;The percentage of people who have a ratio of neutrophils to lymphocytes greater than 3. Timepoint: The beginning of the intervention, 2 and 4 months after the start. Method of measurement: Complete blood count test.;The percentage of people who have a platelet to lymphocyte ratio greater than 150. Timepoint: The beginning of the intervention, 2 and 4 months after the start. Method of measurement: Complete blood count test.;The percentage of people who have cardiac ejection fraction less than 50%. Timepoint: The beginning of the

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDanial Amiri Manjili

Directorate of Health, Rescue & Treatment of Islamic Republic of Iran Police Headquarter

danial.amiri.m@gmail.com+98 21 8123 5481

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026